Breakthrough: Daily pill doubles survival rate in deadliest form of cancer
A new pill called "daraxonrasib" has nearly doubled the survival rate of patients with metastatic pancreatic cancer in a large clinical trial. Cancer specialists call this a breakthrough that could fundamentally change the treatment of one of the deadliest cancers.
